Biocon shares in focus today as US FDA issues four observations for insulin facility
Biocon stock ended 2.05% higher at Rs 276.50 on Thursday against the previous close of Rs 270.95 on BSE. The stock touched an intraday high of Rs 277.60 .
United States Biocon Biologics Drug Administration Biocon Biologics Limited Campus Site Biocon Ltd United States Food
Source: businesstoday.in